4,614
Views
35
CrossRef citations to date
0
Altmetric
Report

Advanced assessment of the physicochemical characteristics of Remicade® and Inflectra® by sensitive LC/MS techniques

, , , , &
Pages 1021-1034 | Received 25 Apr 2016, Accepted 19 May 2016, Published online: 01 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Anurag Rathore & Himanshu Malani. (2022) Need for a risk-based control strategy for managing glycosylation profile for biosimilar products. Expert Opinion on Biological Therapy 22:2, pages 123-131.
Read now
Zaneer Segu, Todd Stone, Claudia Berdugo, Anthony Roberts, Emma Doud & Yunsong Li. (2020) A rapid method for relative quantification of N-glycans from a therapeutic monoclonal antibody during trastuzumab biosimilar development. mAbs 12:1.
Read now
Nobuo Sekiguchi, Chiyomi Kubo, Ayako Takahashi, Kumiko Muraoka, Akira Takeiri, Shunsuke Ito, Mariko Yano, Futa Mimoto, Atsuhiko Maeda, Yuki Iwayanagi, Tetsuya Wakabayashi, Shotaro Takata, Naoaki Murao, Shuichi Chiba & Masaki Ishigai. (2018) MHC-associated peptide proteomics enabling highly sensitive detection of immunogenic sequences for the development of therapeutic antibodies with low immunogenicity. mAbs 10:8, pages 1168-1181.
Read now
Mark Hilliard, William R. Alley$suffix/text()$suffix/text(), Ciara A. McManus, Ying Qing Yu, Sinead Hallinan, John Gebler & Pauline M. Rudd. (2017) Glycan characterization of the NIST RM monoclonal antibody using a total analytical solution: From sample preparation to data analysis. mAbs 9:8, pages 1349-1359.
Read now
Daniel M. Geynisman, Guillermo De Velasco, K. Lea Sewell & Ira Jacobs. (2017) Biosimilar biologic drugs: a new frontier in medical care. Postgraduate Medicine 129:4, pages 460-470.
Read now

Articles from other publishers (30)

Jérôme Castel, Sarah Delaux, Oscar Hernandez-Alba & Sarah Cianférani. (2023) Recent advances in structural mass spectrometry methods in the context of biosimilarity assessment: from sequence heterogeneities to higher order structures. Journal of Pharmaceutical and Biomedical Analysis 236, pages 115696.
Crossref
Radoslaw P. Kozak & Louise Royle. 2023. Liquid Chromatography. Liquid Chromatography 381 402 .
Hyejin Kim, Geul Bang, Ye Eun Park, Moonhee Park, Jung Hoon Choi, Myung Jin Oh, Hyun Joo An, Jong Shin Yoo, Youngja Hwang Park, Jin Young Kim & Heeyoun Hwang. (2022) Advanced assessment through intact glycopeptide analysis of Infliximab’s biologics and biosimilar. Frontiers in Molecular Biosciences 9.
Crossref
Haofeng Sun, Jianyi Liu, Peng Xiao, Yi Zhou, Hongmei Li, Min Shen, Keqi Sun, Xiaojian Wang, Min Zhou & Dewei Song. (2022) Epitope mapping of antibodies in C-reactive protein assay kits by hydrogen-deuterium exchange mass spectrometry explains differential results across kits. Analytical and Bioanalytical Chemistry 414:13, pages 3875-3884.
Crossref
Neh Nupur, Srishti Joshi, Davy Gulliarme & Anurag S. Rathore. (2022) Analytical Similarity Assessment of Biosimilars: Global Regulatory Landscape, Recent Studies and Major Advancements in Orthogonal Platforms. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Bastiaan L. Duivelshof, Steffy Denorme, Koen Sandra, Xiaoxiao Liu, Alain Beck, Matthew A. Lauber, Davy Guillarme & Valentina D’Atri. (2021) Quantitative N-Glycan Profiling of Therapeutic Monoclonal Antibodies Performed by Middle-Up Level HILIC-HRMS Analysis. Pharmaceutics 13:11, pages 1744.
Crossref
Tyler S. Hageman, Michael S. Wrigley & David D. Weis. (2021) Statistical Equivalence Testing of Higher-Order Protein Structures with Differential Hydrogen Exchange-Mass Spectrometry (HX-MS). Analytical Chemistry 93:18, pages 6980-6988.
Crossref
Jingzhong Guo, Huiping Tu, Maheswara Rao B, Anjali Kumari Chillara, Edith Chang & Fouad Atouf. (2021) More comprehensive standards for monitoring glycosylation. Analytical Biochemistry 612, pages 113896.
Crossref
Ximo Zhang, Corey E. Reed, Robert E. Birdsall, Ying Qing Yu & Weibin Chen. (2020) High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from Biotherapeutics Using an Automated LC-MS-Based Solution. SLAS Technology 25:4, pages 380-387.
Crossref
Chris Barton, Xuesong Scott Li, Siyang Peter Li, Brian Flaherty, Lionel Sison, Qiaozhen Lu, Bernice Yeung & Shiaw-Lin Wu. (2020) Impact of Glycosylation on the Comparability of the Higher-Order Structures in Idursulfase by Hydrogen–Deuterium Exchange Mass Spectrometry. Analytical Chemistry 92:12, pages 8306-8314.
Crossref
Harriet Mörtstedt, Åsa Makower, Per-Olof Edlund, Katarina Sjöberg & Agneta Tjernberg. (2020) Improved identification of host cell proteins in a protein biopharmaceutical by LC–MS/MS using the ProteoMiner™ Enrichment Kit. Journal of Pharmaceutical and Biomedical Analysis 185, pages 113256.
Crossref
Elsa Wagner, Olivier Colas, Stéphane Chenu, Alexandre Goyon, Amarande Murisier, Sarah Cianferani, Yannis François, Szabolcs Fekete, Davy Guillarme, Valentina D’Atri & Alain Beck. (2020) Determination of size variants by CE-SDS for approved therapeutic antibodies: Key implications of subclasses and light chain specificities. Journal of Pharmaceutical and Biomedical Analysis 184, pages 113166.
Crossref
Meriem Dadouch, Yoann Ladner, Claudia Bich, Marion Larroque, Christian Larroque, Jacques Morel, Pierre-Antoine Bonnet & Catherine Perrin. (2020) An in-line enzymatic microreactor for the middle-up analysis of monoclonal antibodies by capillary electrophoresis. The Analyst 145:5, pages 1759-1767.
Crossref
Anna C. Robotham & John F. Kelly. 2020. Approaches to the Purification, Analysis and Characterization of Antibody-Based Therapeutics. Approaches to the Purification, Analysis and Characterization of Antibody-Based Therapeutics 1 33 .
Alain Beck, Davy Guillarme, Sandrine Fleury-Souverain, Elsa Bodier-Montagutelli & Renaud Respaud. (2020) Anticorps monoclonaux biosimilaires. médecine/sciences 35:12, pages 1146-1152.
Crossref
Kerene A. Brown, Shanthi Rajendran, Jason Dowd & Derek J. Wilson. (2019) Rapid characterization of structural and functional similarity for a candidate bevacizumab (Avastin) biosimilar using a multipronged mass‐spectrometry‐based approach. Drug Testing and Analysis 11:8, pages 1207-1217.
Crossref
Tyler S. Hageman & David D. Weis. (2019) Reliable Identification of Significant Differences in Differential Hydrogen Exchange-Mass Spectrometry Measurements Using a Hybrid Significance Testing Approach. Analytical Chemistry 91:13, pages 8008-8016.
Crossref
Lamiaa A. Hassan, Sara M. Shatat, Basma M. Eltanany, Medhat A. Al-Ghobashy & Samah S. Abbas. (2019) Stability and biosimilarity assessment of infliximab using an orthogonal testing protocol and statistically-guided interpretation of peptide mapping. Analytical Methods 11:25, pages 3198-3211.
Crossref
Tetsuo Torisu, Hiroaki Oyama & Susumu Uchiyama. (2018) Analysis of Higher Order Structures of Proteins by Hydrogen Deuterium Exchange Mass Spectrometry水素/重水素交換質量分析法によるタンパク質の高次構造解析. Journal of the Mass Spectrometry Society of Japan 66:6, pages 218-221.
Crossref
Masahiro Tsuda, Yuki Otani, Atsushi Yonezawa, Sho Masui, Yasuaki Ikemi, Masaya Denda, Yuki Sato, Shunsaku Nakagawa, Tomohiro Omura, Satoshi Imai, Takayuki Nakagawa, Makoto Hayakari & Kazuo Matsubara. (2018) Analysis of Glycoforms and Amino Acids in Infliximab and a Biosimilar Product Using New Method with LC/TOF-MS. Biological and Pharmaceutical Bulletin 41:11, pages 1716-1721.
Crossref
Kayoko Hayashihara, Kanta Enomoto & Susumu Uchiyama. (2018) Analysis of Primary and Higher Order Structures of Biopharmaceuticals Including Antibody Drugs by Mass Spectrometry質量分析法による抗体医薬などのバイオ医薬品の一次および高次構造解析. Journal of the Mass Spectrometry Society of Japan 66:4, pages 161-163.
Crossref
Devrishi Goswami, Jun Zhang, Pavel V. Bondarenko & Zhongqi Zhang. (2018) MS-based conformation analysis of recombinant proteins in design, optimization and development of biopharmaceuticals. Methods 144, pages 134-151.
Crossref
László Hajba, Ákos Szekrényes, Beáta Borza & András Guttman. (2018) On the glycosylation aspects of biosimilarity. Drug Discovery Today 23:3, pages 616-625.
Crossref
Edward LiErnesto Lobaina. (2017) Application of the FDA Biosimilar Extrapolation Framework to Make Off-Label Determinations. Journal of Managed Care & Specialty Pharmacy 23:12, pages 1227-1232.
Crossref
Othman Montacir, Houda Montacir, Murat Eravci, Andreas Springer, Stephan Hinderlich, Amirhossein Saadati & Maria Kristina Parr. (2017) Comparability study of Rituximab originator and follow-on biopharmaceutical. Journal of Pharmaceutical and Biomedical Analysis 140, pages 239-251.
Crossref
Lisa M. Sedger, Charani Ranasinghe, Michael F. McDermott & Parisa Asvadi. 2017. Immunotherapy - Myths, Reality, Ideas, Future. Immunotherapy - Myths, Reality, Ideas, Future.
Valentina D’Atri, Szabolcs Fekete, Alain Beck, Matthew Lauber & Davy Guillarme. (2017) Hydrophilic Interaction Chromatography Hyphenated with Mass Spectrometry: A Powerful Analytical Tool for the Comparison of Originator and Biosimilar Therapeutic Monoclonal Antibodies at the Middle-up Level of Analysis. Analytical Chemistry 89:3, pages 2086-2092.
Crossref
L. Veillon, S. Zhou & Y. Mechref. 2017. Proteomics in Biology, Part A. Proteomics in Biology, Part A 431 477 .
Louise Royle. 2017. Liquid Chromatography. Liquid Chromatography 183 200 .
Brian A. BaldoBrian A. Baldo. 2016. Safety of Biologics Therapy. Safety of Biologics Therapy 587 596 .